• TUNEL Apoptosis Detection Kit (DAB): Precision in Programmed

  2026-06-16

  Explore the scientific foundations and advanced applications of the TUNEL Apoptosis Detection Kit in apoptosis and DNA fragmentation detection. This article provides a deeper mechanistic analysis and practical assay guidance for tissue and cell research models.

• Reliably Enhance Protein Stability with Protease Inhibitor C

  2026-06-16

  This article offers a scenario-driven, evidence-based perspective on optimizing protein stability in cell viability and lipid droplet assays using the Protease Inhibitor Cocktail (100X H₂O, EDTA Plus) (SKU K4003). It addresses real laboratory challenges, discusses protocol parameters, and compares vendor options, providing actionable guidance for biomedical researchers and lab technicians.

• IBDV VP3 Drives IRF7 Degradation via the Ubiquitin-Proteasom

  2026-06-15

  This study reveals how infectious bursal disease virus (IBDV) exploits its VP3 protein to target interferon regulatory factor 7 (IRF7) for proteasomal degradation, suppressing type I interferon responses and enhancing viral replication in chicken cells. These insights clarify a key mechanism of viral immune evasion and underscore the importance of ubiquitin-proteasome system inhibition in antiviral research.

• TP53 and DNA Damage Response Genes Modulate Calicheamicin Se

  2026-06-15

  This study presents a genome-wide CRISPR/Cas9 screen identifying TP53 and related DNA damage response genes as key modulators of calicheamicin-based ADC efficacy in acute leukemia. The findings refine our understanding of resistance mechanisms and suggest targeted combinatorial strategies to enhance therapeutic response.

• One-step TUNEL Cy5 Apoptosis Detection Kit: Workflow & Insig

  2026-06-14

  Unlock streamlined, high-sensitivity apoptosis detection in both tissue sections and cultured cells with the One-step TUNEL Cy5 Apoptosis Detection Kit. This guide explores advanced experimental strategies, troubleshooting, and the latest protocol upgrades that empower researchers to dissect cell death pathways with precision.

• PYR-41: Inhibitor of Ubiquitin-Activating Enzyme E1 for Prec

  2026-06-13

  PYR-41, a selective inhibitor of Ubiquitin-Activating Enzyme E1, empowers researchers to modulate the ubiquitin-proteasome system with targeted precision. Its unique mechanism enables advanced workflows in inflammation, infection, and apoptosis research, addressing complex questions in protein stability and NF-κB signaling pathway modulation.

• ABT-199 (Venetoclax): Precision Bcl-2 Inhibition in Translat

  2026-06-12

  Explore how ABT-199 (Venetoclax), a highly selective Bcl-2 inhibitor, is redefining apoptosis research and translational oncology. This thought-leadership article integrates mechanistic insights, evidence-based protocols, and strategic guidance—bridging foundational discoveries with emerging clinical applications in hematologic malignancies and beyond.

• AO/PI Double Staining Kit: Practical Cell Viability and Deat

  2026-06-12

  The AO/PI Double Staining Kit enables rapid, simultaneous assessment of viable, apoptotic, and necrotic cells using Acridine Orange and Propidium Iodide staining. This kit is best suited for fluorescence-based cell viability assays in research settings, offering clear discrimination among cell states. It should not be used for applications requiring absolute quantification without further validation or in non-cellular samples.

• Filipin III: Gold-Standard Polyene Macrolide for Membrane Ch

  2026-06-11

  Filipin III, a predominant isomer of the polyene macrolide antibiotic family, is the benchmark probe for cholesterol detection in biological membranes. Its high specificity and robust fluorescence quenching upon cholesterol binding enable precise visualization of membrane cholesterol microdomains in cell biology and biochemistry research.

• Naked Mole-Rat cGAS Enhances DNA Repair and Delays Aging

  2026-06-11

  A recent study uncovers that naked mole-rats possess a uniquely modified cGAS protein that, unlike its human and mouse counterparts, enhances homologous recombination-mediated DNA repair and contributes to delayed aging. This finding identifies a molecular mechanism linking genome stability with longevity and offers new research directions for aging and DNA repair fields.

• GI 254023X: Illuminating ADAM10 Inhibition in Neurovascular

  2026-06-10

  Explore the distinct role of GI 254023X as a selective ADAM10 inhibitor in neurovascular research. Discover how its mechanistic precision advances understanding of cell signaling and vascular protection, with unique insights bridging neurodegeneration and endothelial biology.

• Azilsartan Medoxomil Monopotassium: Applied Workflows & Opti

  2026-06-10

  Azilsartan medoxomil monopotassium (TAK 491) enables rigorously reproducible blood pressure and cardiovascular research thanks to its high affinity, selectivity, and sustained receptor blockade. This guide translates recent breakthroughs into actionable protocols—plus troubleshooting tactics—for maximizing the translational impact of APExBIO’s trusted formulation.

• WP1066: Precision JAK2/STAT3 Inhibition in Cancer and Beyond

  2026-06-09

  Discover how WP1066, a potent JAK2/STAT3 inhibitor, advances cancer and regenerative biology research with unique pathway modulation and translational applications. Explore mechanistic insights, protocol guidance, and innovations not covered in other articles.

• HOXB4-Enhanced MSCs Protect Endothelium via Wnt/β-Catenin in

  2026-06-09

  Lin et al. demonstrate that overexpression of HOXB4 in bone marrow mesenchymal stem cells (BMSCs) confers protection against lipopolysaccharide-induced endothelial injury by activating Wnt/β-catenin signaling. This finding clarifies a mechanistic link between gene-modified MSC therapy and endothelial repair in acute lung injury, with implications for targeted cytotherapy development.

• PYR-41: Selective Inhibitor of Ubiquitin-Activating Enzyme E

  2026-06-08

  PYR-41 is a small molecule inhibitor of Ubiquitin-Activating Enzyme E1, enabling targeted modulation of the ubiquitin-proteasome system. This agent blocks ubiquitin thioester formation, disrupts protein degradation, and is valuable for dissecting NF-κB signaling in inflammation and viral pathogenesis. Rigorous evidence supports its benchmark activity in cell and animal models, but practical limitations exist regarding specificity and solubility.

16247 records 1/1084 page Next 12345 下5页 Last page